JP2008231090A5 - - Google Patents

Download PDF

Info

Publication number
JP2008231090A5
JP2008231090A5 JP2007319333A JP2007319333A JP2008231090A5 JP 2008231090 A5 JP2008231090 A5 JP 2008231090A5 JP 2007319333 A JP2007319333 A JP 2007319333A JP 2007319333 A JP2007319333 A JP 2007319333A JP 2008231090 A5 JP2008231090 A5 JP 2008231090A5
Authority
JP
Japan
Prior art keywords
compound
formula
solvent
methyl
oxopyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007319333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008231090A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2008231090A publication Critical patent/JP2008231090A/ja
Publication of JP2008231090A5 publication Critical patent/JP2008231090A5/ja
Ceased legal-status Critical Current

Links

JP2007319333A 2006-12-13 2007-12-11 3−(4−(2,4−ジフルオロベンジルオキシ)−3−ブロモ−6−メチル−2−オキソピリジン−1(2h)−イル)−n,4−ジメチルベンズアミドを調製する方法 Ceased JP2008231090A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86974806P 2006-12-13 2006-12-13

Publications (2)

Publication Number Publication Date
JP2008231090A JP2008231090A (ja) 2008-10-02
JP2008231090A5 true JP2008231090A5 (https=) 2009-08-27

Family

ID=39365911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007319333A Ceased JP2008231090A (ja) 2006-12-13 2007-12-11 3−(4−(2,4−ジフルオロベンジルオキシ)−3−ブロモ−6−メチル−2−オキソピリジン−1(2h)−イル)−n,4−ジメチルベンズアミドを調製する方法

Country Status (17)

Country Link
US (1) US7906536B2 (https=)
EP (1) EP2102161B1 (https=)
JP (1) JP2008231090A (https=)
KR (1) KR20090090379A (https=)
CN (1) CN101611006A (https=)
AR (1) AR064312A1 (https=)
AT (1) ATE556055T1 (https=)
AU (1) AU2007331199A1 (https=)
BR (1) BRPI0720757A2 (https=)
CA (1) CA2672256C (https=)
IL (1) IL199239A0 (https=)
MX (1) MX2009006266A (https=)
NZ (1) NZ577639A (https=)
RU (1) RU2411236C1 (https=)
TW (1) TW200837057A (https=)
WO (1) WO2008072079A2 (https=)
ZA (1) ZA200903981B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679159B2 (ja) 2010-07-05 2015-03-04 信越化学工業株式会社 希土類金属抽出剤の合成方法、及び希土類金属の溶媒抽出用有機相
WO2014181213A1 (en) 2013-05-10 2014-11-13 Pfizer Inc. Crystalline form of (sa)-(-)-3-(3-bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1 (2h)-yl)-n,4-dimethylbenzamide
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD
MX2022004631A (es) * 2019-10-18 2022-05-24 Fmc Corp Metodos para la preparacion del acido 5-bromo-2-(3-cloropiridin-2- il)-2h-pirazol-3-carboxilico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3286645B2 (ja) * 1993-03-26 2002-05-27 メルシャン株式会社 光学活性1,4−ジヒドロピリジン誘導体およびその製造方法
RS52392B (sr) * 2002-02-14 2013-02-28 Pharmacia Corporation Supstituisani piridinoni kao modulatori p38 map kinaze
CL2004002050A1 (es) * 2003-08-13 2005-06-03 Pharmacia Corp Sa Organizada B Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
WO2006021885A1 (en) * 2004-08-26 2006-03-02 Pfizer Inc. Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
CA2640665A1 (en) * 2006-02-10 2007-08-16 Pfizer Products Inc. Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives

Similar Documents

Publication Publication Date Title
JP2008231090A5 (https=)
US8101609B2 (en) Processes for the preparation of rivaroxaban and intermediates thereof
JP2005525427A5 (https=)
JP2001522828A5 (https=)
PE20040892A1 (es) Antagonistas del receptor muscarinico m3 de acetilcolina
JP2003505458A5 (https=)
JP2003506347A5 (https=)
JP2009533369A5 (https=)
JP2009534471A5 (https=)
JPWO2012102255A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
PE20050077A1 (es) Derivados de 4-pirrolidino-fenil-bencil-eter
JP2015520738A5 (https=)
WO2006046499A1 (ja) インドリン化合物およびその製造方法
RU2010144823A (ru) Гетероциклические ингибиторы мек и способы их применения
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
JP2006522141A5 (https=)
JP2019523772A5 (https=)
JP2006526608A5 (https=)
KR100938369B1 (ko) 신규 4-(2-푸로일)아미노피페리딘, 그의 합성 중간체,그의 제조방법 및 의약으로서의 그의 용도
TW200307545A (en) Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
JP2010526801A5 (https=)
JP2002308858A5 (https=)
JP2009543794A5 (https=)
JP2010516044A5 (https=)
ES2230521T3 (es) Derivados de oxima de piperazina que tienen actividad como antagosnistas del receptor nk-1.